美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Direxion Daily Biotech Top 5 Bull 2X ETF

38.72

+0.36000.94%

成交量：458

成交額：1.77萬

市值：290.40萬

市盈率：- -

高：38.72

開：38.72

低：38.72

收：38.36

52周最高：45.88

52周最低：25.71

股本：7.50萬

流通股本：7.50萬

量比：0.08

換手率：0.61%

股息：0.62

股息率：1.61%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

CHMP推薦吉利德Trodelvy®聯合Keytruda®用於PD-(L)1陽性一線轉移性三陰性乳腺癌

市場消息：美國司法部將恢復併購交易的「二次信息調取」調查流程。

黑石集團：短期內非人工智能企業相關併購交易將趨於冷清。

百濟神州/安進 FIC 雙抗，皮下製劑進入 III 期

數據研究機構Datasite：數據顯示2026上半年全球併購啓動項目數量按年上升31%，併購交易熱度持續升温。

argenx(ARGX)二季度產品淨銷售額達15.16億美元按年增長60%

數據簡報-邦迪布吉奧埃博拉病毒：正在研發哪些疫苗和治療方法

吉利德與默克聯合研發的每周服用一次的艾滋病口服藥在晚期臨床試驗中成功抑制了病毒

安進就股東提起的指控其隱瞞107億美元税單的訴訟達成和解

美國研究綜述-高露潔-棕欖、IBM、聯合健康

Leerink Partners下調吉利德科學評級至「與大盤持平」，目標價大幅調降至127美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/TBXU/news?page=8"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":38.7201,"timestamp":1789400457695,"preClose":38.3601,"halted":0,"volume":458,"delay":0,"changeRate":0.00938475134319252,"floatShares":75001,"shares":75001,"eps":0,"marketStatus":"交易中","change":0.36,"latestTime":"09-14 11:49:29 EDT","open":38.72,"high":38.7201,"low":38.72,"amount":17734.251433999998,"amplitude":0.000003,"askPrice":39.29,"askSize":400,"bidPrice":39.24,"bidSize":400,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789416000000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":38.3601,"sharesOutstanding":100001,"nav":38.336,"aum":2875239.83,"dividendRate":0.016059,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":38.5301,"preClose":38.3601,"latestTime":"16:10 EDT","volume":6,"amount":230.1604,"timestamp":1789157404900,"change":0.17,"changeRate":0.004432,"amplitude":0},"volumeRatio":0.079407},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":75001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.079407,"shares":75001,"dividePrice":0.6218,"high":38.7201,"amplitude":0.000003,"preClose":38.3601,"low":38.72,"week52Low":25.71,"pbRate":"--","week52High":45.88,"institutionHeld":0,"latestPrice":38.7201,"eps":0,"divideRate":0.016059,"volume":458,"delay":0,"ttmEps":0,"open":38.72,"prevYearClose":31.065,"prevWeekClose":38.3601,"prevMonthClose":42.9245,"prevQuarterClose":32.1223,"fiveDayClose":44.3833,"twentyDayClose":37.6716,"sixtyDayClose":29.86},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1185859812","title":"CHMP推薦吉利德Trodelvy®聯合Keytruda®用於PD-(L)1陽性一線轉移性三陰性乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1185859812","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185859812?lang=zh_tw&edition=fundamental","pubTime":"2026-07-24 18:29","pubTimestamp":1784888958,"startTime":"0","endTime":"0","summary":"欧洲药品管理局人用药品委员会（CHMP）近日给出推荐意见，支持吉利德科学的Trodelvy®与Keytruda®联合使用，用于治疗PD-(L)1阳性的一线转移性三阴性乳腺癌患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","SG9999015986.USD","LU1674673428.USD","LU0320765992.SGD","BMED","LU0289739699.SGD","LU1430594728.SGD","IBB","LU1778281490.HKD","SG9999015945.SGD","LU0965509283.SGD","LU1839511570.USD","LU2468319806.SGD","BIB","LU1674673691.USD","LU0889565916.HKD","TMED","BK4532","LU0823416689.USD","LU0122379950.USD","LU1571399168.USD","LU1061106388.HKD","LU1057294990.SGD","BK4550","BK4583","LU0058720904.USD","LU2087621335.USD","LU2089984988.USD","LU0965509010.AUD","LU1066053197.SGD","LU0234570918.USD","IE0002270589.USD","IE00BSNM7G36.USD","LU1934455194.USD","IE00BZ1G4Q59.USD","GILD","BK4139","LU0965508806.USD","IE00B19Z3581.USD","LU2324357040.USD","LU1934455863.HKD","MEDI","BK4566","BBH","LU1023059063.AUD","BK4578","IE00B3T34201.USD","BK4568","BK4588","LU1585245621.USD","LU1066051498.USD","SG9999015952.SGD","LU1934455277.USD","BK4585","LU0114720955.EUR","IBBQ","LU0882574055.USD","LU2112291526.USD","IE00B7SZLL34.SGD","LU0109394709.USD","IE00BKVL7J92.USD","LU0965509101.SGD","LU0861579265.USD","LU1037948541.HKD","TBXU","LU1037948897.HKD","SG9999015978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653726128","title":"市場消息： 美國司法部將恢復併購交易的 「二次信息調取」 調查流程。","url":"https://stock-news.laohu8.com/highlight/detail?id=2653726128","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653726128?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 22:21","pubTimestamp":1784816467,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CANC","IEFN","RSPH","IBBQ","PEVC","BK4585","GTPE","MMID","PSP","PRVT","FFSM","PBPH","AAUM","DFMC","UYG","MNA","VXF","ACTV","IYH","TMED","RFG","BK4588","TBXU","XLFI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653728536","title":"黑石集團： 短期內非人工智能企業相關併購交易將趨於冷清。","url":"https://stock-news.laohu8.com/highlight/detail?id=2653728536","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653728536?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 20:44","pubTimestamp":1784810659,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ARTY","AGIX","CHAT","QID","PSP","XLFI","CWC","LCLG","TARK","AIBU","TBXU","IYH","UYG","MVPS","IEFN","NEWZ","PBPH","PEVC","VUSE","ACTV","CPNQ","QSWN","BX","AIFD","QTOC","QQA","TECY","MFIG","PRVT","NBDS","AAUM","MNA","DFMC","GTPE","KOMP","CANC","VXF","RFG","MMID","RSPH","TMED","AQGX","DQJN","PBOT","FFSM","AIQU","OGIG","WPAI","GK","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653074709","title":"百濟神州/安進 FIC 雙抗，皮下製劑進入 III 期","url":"https://stock-news.laohu8.com/highlight/detail?id=2653074709","media":"新浪医药","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653074709?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 19:30","pubTimestamp":1784806200,"startTime":"0","endTime":"0","summary":"7 月 22 日，药物临床试验登记与信息公示平台显示，安进和百济神州共同登记了一项在接受含铂一线化疗后的复发性广泛期小细胞肺癌试验参与者中比较 Tarlatamab皮下给药与静脉给药的 III 期研究DeLLphi-315。在皮下剂型的开发方面，安进和百济神州于 2024 年 9 月启动了一项在广泛期小细胞肺癌受试者中评价 Tarlatamab 皮下给药的安全性、耐受性、药代动力学和初步抗肿瘤活性的 Ib 期研究 DeLLphi-308。而本次启动的DeLLphi-315 研究是塔拉妥单抗皮下给药方案启动的首个 III 期临床试验。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-07-23/doc-iniivazc5268721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["TBXU","BIB","AMGN","IE00BFTCPJ56.SGD","ONC","LU1770034418.SGD","LU1251922891.USD","BK4139","LU1969619763.USD","PBE","06160","III","IE0002141913.USD","BK1500","LU1983299246.USD","LU1719994722.HKD","BK1588","BK4585","LU0320765992.SGD","LU2112291526.USD","LU2242646821.SGD","IE00BJT1NW94.SGD","LU2328871848.SGD","BK4134","LU0889565916.HKD","BK4588","LU1061106388.HKD","LU0289739699.SGD","LU0868494617.USD","LU0588546209.SGD","IBBQ","BK4534","IBB","LU0058720904.USD","LU1571399168.USD","LU2242652126.USD","IE00B4R5TH58.HKD","BBH","LU2468319806.SGD","SG9999001440.SGD","BK4581","LU0122379950.USD","PJP","BK1583","BK4599","LU1303224171.USD","IE0009355771.USD","KURE","688235","LU0307460666.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653744105","title":"數據研究機構Datasite：數據顯示2026上半年全球併購啓動項目數量按年上升31%，併購交易熱度持續升温。","url":"https://stock-news.laohu8.com/highlight/detail?id=2653744105","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653744105?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 19:15","pubTimestamp":1784805342,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MMID","ACTV","AAUM","DFMC","FFSM","IYH","RFG","BK4588","EVNT","TMED","RSPH","PEVC","BK4585","KNO","IBBQ","PSP","CANC","PRVT","XLFI","PEX","VXF","TBXU","MNA","WSML","IEFN","GTPE","UYG","PBPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653749341","title":"argenx(ARGX)二季度產品淨銷售額達15.16億美元 按年增長60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653749341","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653749341?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 18:18","pubTimestamp":1784801894,"startTime":"0","endTime":"0","summary":"金吾财讯 | 全球自身免疫疾病龙头生物科技公司 argenx 发布了2026年第二季度及上半年财报。其中，2026年第二季度，公司实现产品净销售额 15.16亿美元，同比大幅增长 60%，环比增长 17%。资金储备方面，截至2026年6月30日，argenx 拥有的现金、现金等价物及流动金融资产达 52亿美元，显著高于2025年底的44亿美元，为后续临床研发及商业化扩张提供了雄厚的资金屏障。截至2026年底，argenx 预计将有10款药物分子处于临床研发阶段。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/ODM0ODU4NWZiOGY2NDQ4NTA4OTM0NDg5MTI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ODM0ODU4NWZiOGY2NDQ4NTA4OTM0NDg5MTI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302939","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","IE0002141913.USD","BK4505","LU0109394709.USD","LU1983260115.SGD","BK4588","IBB","IE00BFTCPJ56.SGD","IE0009355771.USD","ARGX","BK4585","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU2324357040.USD","LU0889565916.HKD","TBXU","BK4139","IE0034235188.USD","IE00B4R5TH58.HKD","FMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653618768","title":"數據簡報-邦迪布吉奧埃博拉病毒：正在研發哪些疫苗和治療方法","url":"https://stock-news.laohu8.com/highlight/detail?id=2653618768","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653618768?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 20:52","pubTimestamp":1784724736,"startTime":"0","endTime":"0","summary":"数据简报-邦迪布吉奥埃博拉病毒：正在研发哪些疫苗和治疗方法更新疫情数据，补充临床试验进展及诊断检测详情Mariam Sunny/Jennifer Rigby路透7月22日-全球卫生部门正争分夺秒地寻找医疗方案，以遏制刚果民主共和国东部由邦迪布吉奥  埃博拉病毒株引发的疫情。与更常见的扎伊尔毒株不同，目前尚无针对邦迪布吉奥毒株的获批疫苗或治疗方法。据该公司称，实验室研究表明该药物对邦迪布吉奥埃博拉病毒具有活性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nL4T43O1A0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1003076772.USD","LU1066051498.USD","LU1273509221.SGD","LU0857590862.USD","IE0009355771.USD","LU0130517989.USD","LU1046234339.USD","LU0208291251.USD","RXL","XLV","IE00B4R5TH58.HKD","LU0823434740.USD","LU1323610961.USD","03165","LU2491049909.HKD","LU2468319806.SGD","LU1839511570.USD","LU0158827948.USD","LU0942090050.USD","BK4588","LU0823434583.USD","BK4501","LU2125909247.SGD","LU1119994496.HKD","IE00BN8TJ469.HKD","IE00BJT1NW94.SGD","LU0171293334.USD","LU0648001328.SGD","LU2237443622.USD","LU1291159041.SGD","IE00BKVL7J92.USD","SG9999014567.USD","LU1571399168.USD","LU0784385840.USD","LU1037948897.HKD","LU2360032135.SGD","LU2023250843.SGD","LU0868494708.USD","LU0128525689.USD","LU1093756325.SGD","LU0320765992.SGD","LU0320765646.SGD","LU0823399737.USD","LU0868494617.USD","LU1069347547.HKD","LU1934455863.HKD","LU0390134368.USD","LU1162221912.USD","LU1116320737.USD","LU1064927863.SGD","BK4198","LU1829250122.USD","LU0098860793.USD","LU0499090636.EUR","LU1983299246.USD","LU0575583348.USD","LGHT","LU1093756168.USD","BK5011","LU2361045086.USD","LU1267930813.SGD","BK4578","LU2491050154.USD","LU0070302665.USD","LU1934455277.USD","LU2089284900.SGD","LU0203345920.USD","LU1917777945.USD","LU0289739699.SGD","LU1880407215.USD","LU0889565080.SGD","IE0002270589.USD","LU1084165304.USD","LU0976567544.SGD","LU0029864427.USD","BK4551","IBB","LU0882574055.USD","BK4516","LU0238689110.USD","LU1496350171.SGD","LU0211326839.USD","LU0122379950.USD","LU0964806797.USD","BIB","IE0002141913.USD","LU0077335932.USD","LU0265550946.USD","LU0211328371.USD","AZN.UK","LU2023251221.USD","MRNY","IE0034235188.USD","LU2237443978.SGD","LU1430594728.SGD","LU2355687059.USD","LU1487256676.USD","LU0792757196.USD","BK4583","SG9999015952.SGD","LU0689626769.HKD","SG9999015986.USD","LU2114397693.USD","LU0640478417.SGD","PAWZ","LU1066051225.USD","LU0114720955.EUR","LU1153585028.USD","JDOC","BK4533","IE00B2B36J28.USD","SG9999001440.SGD","LU0047473722.SGD","LU3187612489.SGD","LU1037948541.HKD","LU1019632923.USD","LU0211327993.USD","LU1934455194.USD","LU1170363599.USD","LU0784385170.HKD","LU0496365809.HKD","LU0965509101.SGD","LU1674673428.USD","LU1035773651.USD","LU2361044949.HKD","REGN","LU1267930573.SGD","TRUH","MEDI","LU1585245621.USD","BK4007","LU1104425308.USD","LU0738911758.USD","SG9999015945.SGD","LU2362541513.USD","LU1814569148.SGD","LU1941712348.USD","LU1267930490.SGD","SG9999013999.USD","LU0965509010.AUD","LU0011850046.USD","SG9999002232.USD","TBXU","LU1989772923.USD","IE00B3T34201.USD","LU1355424745.HKD","LU0526926950.USD","BK4548","LU0661504455.SGD","LU0887340254.USD","LU1261432733.SGD","LU2362540622.SGD","688317","MRNA","LU1019634622.SGD","LU2237443465.HKD","LU0784383803.USD","LU0266013472.USD","LU0130102774.USD","LU2293690082.USD","IE00B7SZLL34.SGD","SG9999015341.SGD","BK4585","LU0006306889.USD","IE00BLSP4452.SGD","LU0310799852.SGD","SG9999015978.USD","IE00BSNM7G36.USD","LU0827474353.SGD","LU1929549753.HKD","LU0920840948.USD","LU1481600234.SGD","LU1674673691.USD","BK4559","LU2023250504.SGD","LU1267930227.SGD","LU1699723380.USD","LU2106854487.HKD","LU0052756011.USD","GILD","LU1023059063.AUD","LU1989772840.SGD","BK0239","LU0949170426.SGD","LU1196032939.SGD","LU0171276677.USD","LU2361044865.SGD","SG9999014559.SGD","LU1989771016.USD","LU1066051811.HKD","LU2125154935.USD","LU2237443549.SGD","LU0211326755.USD","MRK","LU0985320562.USD","IDNA","HRTS","LU2362541273.HKD","SG9999002224.SGD","LU0960981461.USD","FTXH","IE00BFTCPJ56.SGD","LU0211331839.USD","LU0965508806.USD","LU0234570918.USD","LU0980610538.SGD","LU1051770623.HKD","LU2237443382.USD","BK4534","LU2089984988.USD","LU1153584641.USD","LU0757432116.USD","IE000M9KFDE8.USD","LU2279689827.SGD","BK4139","LU0861579265.USD","LU1880407132.USD","SG9999015358.SGD","LU0234572021.USD","IE00BJJMRZ35.SGD","LU1496350502.SGD","LU2125909593.SGD","LU0053666078.USD","LU1301847155.USD","IXJ","LU0058720904.USD","IE00BZ1G4Q59.USD","LU2087621335.USD","LU0345777147.USD","LU2357627491.SGD","SGXZ57979304.SGD","WDNA","LU2089283258.USD","LU1078025761.USD","PPH","SG9999001176.USD","GNOM","LU1863844665.USD","FHLC","LU2108987350.USD","BMED","LU2112291526.USD","OSUR","LU1923622614.USD","LU0310800379.SGD","LU0124676726.USD","BK4568","LU2133065610.SGD","SG9999001176.SGD","IYH","LU1061106388.HKD","LU0203347892.USD","IE00B19Z3B42.SGD","LU0965509283.SGD","LU0972486137.USD","SG9999014575.USD","LU2237443895.HKD","IE00BKPKM643.USD","LU2091194634.USD","LU0320765489.SGD","LU1003077747.HKD","LU1863844749.USD","BBH","BK4566","IHE","TMED","LU2433249047.HKD","LU0345777659.USD","LU2125154778.USD","LU0432979614.USD","GDOC","IE00B19Z3581.USD","LU0545039389.USD","LU0557290698.USD","LU0823416689.USD","LU2491050071.SGD","MRNX","LU1066053197.SGD","IE00BLSP4239.USD","LU0997586515.USD","IE00BBT3K403.USD","SG9999014542.SGD","LU1201861249.SGD","LU1015430645.USD","LU0920783379.SGD","LU1057294990.SGD","LU1116320901.HKD","LU0997586432.USD","LU0859254822.USD","BK4550","LU1481599808.USD","LU2237438978.USD","BK4532","LU2293690249.USD","LU0106261372.USD","LU2539964713.USD","LU0265550359.USD","LU0889565916.HKD","LU0553294199.USD","LU2461242641.AUD","LU0128525929.USD","LU2324357040.USD","LU1778281490.HKD","LU0949170772.SGD","LU0310800965.SGD","IE00B1BXHZ80.USD","IBBQ","LU1974910355.USD","LU0963555726.SGD","VHT","LU0109394709.USD","LU0784384876.USD","LU0957799991.USD","LU0889566641.SGD","LU0477156953.USD","LU0047473722.EUR","LU0969580561.USD","LU0708994859.HKD","LU1941712264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653204798","title":"吉利德與默克聯合研發的每周服用一次的艾滋病口服藥在晚期臨床試驗中成功抑制了病毒","url":"https://stock-news.laohu8.com/highlight/detail?id=2653204798","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653204798?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 01:23","pubTimestamp":1784654592,"startTime":"0","endTime":"0","summary":"吉利德与默克联合研发的每周服用一次的艾滋病口服药在晚期临床试验中成功抑制了病毒路透7月21日-吉利德科学公司和默克公司周二表示，其正在试验中的每周服用一次的艾滋病毒口服药在两项晚期临床试验中成功抑制了病毒，这为该药的监管申报提供了支持，该疗法有望成为此类疾病治疗中首个此类方案。默克公司的每日一次艾滋病口服复方制剂Idvynso已于4月获得美国食品药品监督管理局批准 ，为艾滋病患者提供了另一种治疗选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nL4T43N1N1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","BIB","GILD","XLV","LU1023059063.AUD","LU2089984988.USD","JDOC","RXL","LU0266013472.USD","IXJ","VHT","BMED","PPH","FHLC","LU2023250843.SGD","LU1983299246.USD","LU1291159041.SGD","IHE","LU2324357040.USD","TRUH","LU0432979614.USD","FTXH","SG9999015952.SGD","IYH","LU1699723380.USD","LU0868494708.USD","SG9999014542.SGD","IE00BJJMRZ35.SGD","LU1923622614.USD","LU1929549753.HKD","MRK","LU0889565916.HKD","IE00B2B36J28.USD","LU1989771016.USD","LU0861579265.USD","GDOC","IBBQ","LU0058720904.USD","IBB","HRTS","BBH","LU1093756168.USD","LU1778281490.HKD","LU2087621335.USD","LU1941712348.USD","PAWZ","SG9999001176.USD","TMED","MEDI","LU1066053197.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653206285","title":"安進就股東提起的指控其隱瞞107億美元税單的訴訟達成和解","url":"https://stock-news.laohu8.com/highlight/detail?id=2653206285","media":"路透中文","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653206285?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 23:07","pubTimestamp":1784646437,"startTime":"0","endTime":"0","summary":"安进就股东提起的指控其隐瞒107亿美元税单的诉讼达成和解Jonathan Stempel路透纽约7月21日-安进公司就一起指控其延迟披露可能因六年税款申报不足而需向美国国税局补缴107亿美元的诉讼，达成了一项7400万美元的和解协议。安进否认有任何不当行为，并于周二表示仍认为这些指控毫无依据。美国国税局就安进公司所谓的“转让定价”做法，要求其补缴87亿美元税款及利息，并处以20亿美元罚款。安进公司表示，美国税务法院的裁决可能于今年作出。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nL4T43N1GC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0122379950.USD","BK4533","LU1061106388.HKD","IBB","LU1023059063.AUD","LU1983299246.USD","LU0320765992.SGD","BK4581","BK4588","BK4585","IBBQ","LU2089984988.USD","IE0002141913.USD","IE00B4R5TH58.HKD","TBXU","LU0289739699.SGD","IE00B2B36J28.USD","LU1571399168.USD","BK4599","SG9999001440.SGD","LU2242646821.SGD","LU0109394709.USD","LU0889565916.HKD","BBH","LU2112291526.USD","PBE","BIB","LU0058720904.USD","LU2242652126.USD","LU1057294990.SGD","IE00BFTCPJ56.SGD","PJP","BK4534","LU2468319806.SGD","AMGN","IE0009355771.USD","BK4139","LU0868494617.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653622222","title":"美國研究綜述-高露潔-棕欖、IBM、聯合健康","url":"https://stock-news.laohu8.com/highlight/detail?id=2653622222","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653622222?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 15:58","pubTimestamp":1784620725,"startTime":"0","endTime":"0","summary":"美国研究综述-高露洁-棕榄、IBM、联合健康路透7月21日-周二，华尔街证券分析师下调了多家在美国上市公司的评级和目标股价，其中包括高露洁-棕榄、IBM和联合健康集团。股票按字母顺序排列。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nL4S43N0GR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRWV","IIPR","JDOC","KRG","KMB","AVB","APPS","IBM","ENR","BOKF","KVUE","GILD","LB","CHD","FRT","CURB","BRBR","UNH","PG","LW","UNHU","GDOC","DT","DPZ","FHLC","HNGE","BXP","EPC","KTB","BRX","IBBQ","STZ","LINE","CTVA","BGS","LYV","MSGE","ESS","MAC","CL","INDS","TDIV","ALX","FWONK","DDOG","TBXU","CLX","CPT","FAF","EGP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169878111","title":"Leerink Partners下調吉利德科學評級至「與大盤持平」，目標價大幅調降至127美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1169878111","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169878111?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 12:03","pubTimestamp":1784606620,"startTime":"0","endTime":"0","summary":"投资银行Leerink Partners调整了对生物技术公司吉利德科学的股票评级。该机构将其评级从原先的“跑赢大盘”下调至“与大盘持平”，反映出其对该公司近期前景更为审慎的看法。\n与此同时，Leerink Partners也显著下调了吉利德科学的目标股价，从每股146美元大幅削减至127美元。这一调整意味着该机构对该公司未来股价的预期有所降低。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1585245621.USD","IBB","IE0002270589.USD","MEDI","LU1934455194.USD","SG9999015952.SGD","GILD","LU1061106388.HKD","LU1934455863.HKD","BK4532","LU1023059063.AUD","BK4550","LU2087621335.USD","IE00BKVL7J92.USD","LU0058720904.USD","LU0965509101.SGD","LU2324357040.USD","IE00B7SZLL34.SGD","LU0965508806.USD","LU0861579265.USD","BK4583","LU1037948897.HKD","LU0882574055.USD","TBXU","LU0320765992.SGD","LU1430594728.SGD","LU0965509283.SGD","LU0289739699.SGD","LU0109394709.USD","LU1037948541.HKD","SG9999015978.USD","LU0965509010.AUD","LU0889565916.HKD","IE00B19Z3581.USD","LU0234570918.USD","LU1934455277.USD","SG9999015986.USD","BK4139","BMED","LU0114720955.EUR","BK4585","LU1066053197.SGD","LU0122379950.USD","IE00BZ1G4Q59.USD","LU1057294990.SGD","LU1778281490.HKD","BK4566","LU2468319806.SGD","LU1674673428.USD","IE00B3T34201.USD","LU2112291526.USD","LU1674673691.USD","BK4578","LU1066051498.USD","BIB","LU2089984988.USD","LU0823416689.USD","IBBQ","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","BK4568","LU1839511570.USD","LU1571399168.USD","BBH","SG9999015945.SGD","TMED","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":8,"totalSize":151,"code":"91000000","status":"200"}]}}